Inflarx Nv Stock Probability of Future Stock Price Finishing Over 15.23

IFRX Stock  USD 2.36  0.05  2.16%   
InflaRx NV's future price is the expected price of InflaRx NV instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of InflaRx NV performance during a given time horizon utilizing its historical volatility. Check out InflaRx NV Backtesting, InflaRx NV Valuation, InflaRx NV Correlation, InflaRx NV Hype Analysis, InflaRx NV Volatility, InflaRx NV History as well as InflaRx NV Performance.
For more information on how to buy InflaRx Stock please use our How to Invest in InflaRx NV guide.
  
At this time, InflaRx NV's Price Book Value Ratio is fairly stable compared to the past year. Price To Book Ratio is likely to rise to 0.83 in 2024, whereas Price To Sales Ratio is likely to drop 788.01 in 2024. Please specify InflaRx NV's target price for which you would like InflaRx NV odds to be computed.

InflaRx NV Target Price Odds to finish over 15.23

The tendency of InflaRx Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over $ 15.23  or more in 90 days
 2.36 90 days 15.23 
close to zero percent
Based on a normal probability distribution, the odds of InflaRx NV to move over $ 15.23  or more in 90 days from now is close to zero percent (This InflaRx NV probability density function shows the probability of InflaRx Stock to fall within a particular range of prices over 90 days) . Probability of InflaRx NV price to stay between its current price of $ 2.36  and $ 15.23  at the end of the 90-day period is about 5.24 .
Given the investment horizon of 90 days InflaRx NV has a beta of 0.38. This usually indicates as returns on the market go up, InflaRx NV average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding InflaRx NV will be expected to be much smaller as well. Additionally InflaRx NV has an alpha of 0.8048, implying that it can generate a 0.8 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   InflaRx NV Price Density   
       Price  

Predictive Modules for InflaRx NV

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as InflaRx NV. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.112.196.76
Details
Intrinsic
Valuation
LowRealHigh
0.224.428.99
Details
Naive
Forecast
LowNextHigh
0.042.176.73
Details
5 Analysts
Consensus
LowTargetHigh
9.8510.8212.01
Details

InflaRx NV Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. InflaRx NV is not an exception. The market had few large corrections towards the InflaRx NV's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold InflaRx NV, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of InflaRx NV within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.80
β
Beta against Dow Jones0.38
σ
Overall volatility
0.37
Ir
Information ratio 0.17

InflaRx NV Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of InflaRx NV for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for InflaRx NV can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
InflaRx NV appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 63.09 K. Net Loss for the year was (42.67 M) with profit before overhead, payroll, taxes, and interest of 0.
InflaRx NV currently holds about 23.68 M in cash with (37.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.54.
InflaRx NV has a poor financial position based on the latest SEC disclosures
Latest headline from thelincolnianonline.com: Werewolf Therapeutics, Inc. Shares Sold by Point72 Asset Management L.P.

InflaRx NV Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of InflaRx Stock often depends not only on the future outlook of the current and potential InflaRx NV's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. InflaRx NV's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding54.9 M
Cash And Short Term Investments90.3 M

InflaRx NV Technical Analysis

InflaRx NV's future price can be derived by breaking down and analyzing its technical indicators over time. InflaRx Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of InflaRx NV. In general, you should focus on analyzing InflaRx Stock price patterns and their correlations with different microeconomic environments and drivers.

InflaRx NV Predictive Forecast Models

InflaRx NV's time-series forecasting models is one of many InflaRx NV's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary InflaRx NV's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about InflaRx NV

Checking the ongoing alerts about InflaRx NV for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for InflaRx NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
InflaRx NV appears to be risky and price may revert if volatility continues
The company reported the previous year's revenue of 63.09 K. Net Loss for the year was (42.67 M) with profit before overhead, payroll, taxes, and interest of 0.
InflaRx NV currently holds about 23.68 M in cash with (37.81 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.54.
InflaRx NV has a poor financial position based on the latest SEC disclosures
Latest headline from thelincolnianonline.com: Werewolf Therapeutics, Inc. Shares Sold by Point72 Asset Management L.P.

Additional Tools for InflaRx Stock Analysis

When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.